THE UNIVERSITY OF NEW SOUTH WALES AND THE NATIONAL DRUG AND ALCOHOL RESEARCH CENTRE (NATIONAL CANNABIS PREVENTION AND INFORMATION CENTRE)
PARTICIPANT INFORMATION STATEMENT AND CONSENT FORM
(CURRENT PRACTICES IN THE TREATMENT OF CANNABIS)
You are invited to participate in a study of the current practices in the treatment of cannabis. We (NCPIC) hope to learn about the types and details of treatment on offer nationally. You were selected as a possible participant in this study because your organisation is accessed by clients who may have a cannabis use disorder.
Cannabis accounts for one in five presentations to drug and alcohol services. Despite this, we know very little about this population and the efficacy of treatments available. This is the first ever national survey looking at what treatments are on offer nationally to cannabis users. We anticipate that results from this survey will help identify any gaps in treatment delivery and improve accessibility, which will ultimately benefit service providers. Your clinical insights are an important part of this process.
The questionnaire is structured into four parts:
1. Information about the person completing the survey
2. General Information about your organisation
3. Information about the types of treatment your organisation offers
4. Profile of clients
You may need to gather information about the service prior to completing this survey. Therefore, we recommend that a clinical manager maybe the most appropriate person to complete this survey. In addition we will be asking for your opinions and in some areas, your best guess. We appreciate you may not have direct access to all the information we are collecting, but feel its important for us to collect information that accurately reflect the state of cannabis treatment in Australia. For your convenience this survey is available on-line and in paper form.
We cannot and do not guarantee or promise that you will receive any benefits from this study. In the long-term, however, the information collected from treatment agencies will help to identify gaps in service delivery and assist in the development of clinical guidelines that treatment agencies can access in the future.
Any information that is obtained in connection with this study and that can be identified with you will remain confidential and will be disclosed only with your permission, except as required by law. If you give us your permission by signing this document, we plan to publish the results on the NCPIC website and in a peer reviewed journal. In any publication, information will be provided in such a way that you cannot be identified.
Complaints may be directed to the Ethics Secretariat, The University of New South Wales, SYDNEY 2052 AUSTRALIA (phone 9385 4234, fax 9385 6648, email ethics.sec@unsw.edu.au. Any complaint you make will be investigated promptly and you will be informed out the outcome.
Your decision whether or not to participate will not prejudice your future relations with the University of New South Wales and/or NDARC. If you decide to participate, you are free to withdraw your consent and to discontinue participation at any time without prejudice.
If you have any questions, please feel free to ask us. If you have any additional questions later, Ms Amie Frewen (a.frewen@unsw.edu.au 02 93850308) will be happy to answer them.
|